Vivia Biotech

Vivia Biotech is a preclinical and translational CRO specializing in ex vivo drug screening using patient samples. Our models preserve the native microenvironment, enabling precise evaluation of drug efficacy and mechanisms of action in hematological malignancies, solid tumors, and autoimmune diseases- Enhance Translational Success: Predict drug responses in physiologically relevant models that mirror in-patient biology- Optimize Candidate Selection: Integrate functional assays with molecular biomarkers to refine decision-making- Access High-Quality Patient Samples: Well-characterized samples with detailed clinical and molecular data- Reduce Development Timelines: Generate robust data for regulatory submissions and scientific publications- Increase Confidence in Clinical Progression: Select the most promising compounds before costly clinical trials. With 15+ years of expertise, collaborations with 100+ pharma and biotech companies, and a track record of over 80% returning clients, we provide flexible, data-driven solutions to accelerate drug development. Partner with Vivia Biotech to bring clinically relevant insights to your preclinical strategy.